
|Articles|November 5, 2015 (Updated: November 15, 2020)
Pediatric Drug Development & Therapeutics
Author(s)DIA
Advertisement
DIA’s Editor-in-Chief Stephen P. Spielberg, MD, PhD, FAAP, and Ronald Portman, MD, FAAP, discuss the Pediatric Drug Development & Therapeutics series of articles and how they can help inform the future of pediatric drug development on DIA’s podcast channel,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Real-World Data Brings New Insights to Natural History of Disease Studies
5




